Cardiovascular Risk Reduction 2 FDA-approved to reduce the risk of major cardiovascular events (heart attack, stroke, cardiovascular death) in adults with type 2 diabetes and established cardiovascular disease
The most common adverse events for adolescents were gastrointestinal disorders, reported by 62% of those in the semaglutide group
GLP-1 Weight Loss Physician-supervised GLP-1 therapy with monthly check-ins and at-home delivery
It is not a replacement for diagnosis, and it is not a reason to stop standard care on your own
For some patients, losing weight can lead to better blood pressure control and improved heart function
Heres What to Ask Yourself Before adding any supplement to your routine, it's worth considering the following questions: Do you frequently experience joint or muscle fatigue from training or everyday stress